Do STAT3 inhibitors have potential in the future for cancer therapy?

QR Code

Do STAT3 inhibitors have potential in the future for cancer therapy?

Bibliographic Details
Main Authors:	Wong, A., Hirpara, J., Pervaiz, Shazib, Eu, J., Sethi, G., Goh, B.
Format:	Journal Article
Published:	2017
Online Access:	http://hdl.handle.net/20.500.11937/56081

Similar Items

Targeting transcription factor STAT3 for cancer prevention and therapy.
by: Chai, E., et al.
Published: (2015)

Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
by: Siveen, K., et al.
Published: (2013)

Overexpression of Bcl-2 induces STAT-3 activation via an increase in mitochondrial superoxide.
by: Kang, J., et al.
Published: (2015)

Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies
by: Wong, A., et al.
Published: (2015)

Potential role of genipin in cancer therapy
by: Shanmugam, M., et al.
Published: (2018)

Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance
by: Hirpara, J., et al.
Published: (2019)

Activation of surrogate death receptor signaling triggers peroxynitrite-dependent execution of cisplatin-resistant cancer cells
by: Seah, S., et al.
Published: (2015)

γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: Potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent
by: Rajendran, P., et al.
Published: (2011)

Aberrant localization of apoptosis protease activating factor-1 in lipid raft sub-domains of diffuse large B cell lymphomas
by: Hirpara, J., et al.
Published: (2016)

COX-2 inhibitors: a potential target for drug therapy in the management of colorectal cancer
by: Ryan, A R, et al.
Published: (1999)

Crosstalk between Bcl-2 family and Ras family small GTPases: potential cell fate regulation?
by: Kang, J., et al.
Published: (2013)

Potential role of targeted therapies in the treatment of triple-negative breast cancer
by: Jia, L., et al.
Published: (2016)

Photodynamic therapy: current trends and potential future role in the treatment of bladder cancer
by: Kochergin, Maxim, et al.
Published: (2024)

The role of resveratrol in cancer therapy
by: Ko, J., et al.
Published: (2017)

Do free-range systems have potential to improve broiler welfare in the tropics?
by: Sánchez-Casanova, R., et al.
Published: (2020)

Do Asian women have endometrial cancer at a younger age?
by: Awang, Mokhtar, et al.
Published: (2014)

The STAT3-Ser/Hes3 signaling axis in cancer
by: Poser, Steven, et al.
Published: (2014)

Reactive oxygen species and oncoprotein signaling-a dangerous liaison
by: Chong, S., et al.
Published: (2018)

ROS, autophagy, mitochondria and cancer: Ras, the hidden master?
by: Bellot, G., et al.
Published: (2013)

gRASping the redox lever to modulate cancer cell fate signaling
by: Foo, C., et al.
Published: (2019)

Bcl-2: A prime regulator of mitochondrial redox metabolism in cancer cells
by: Low, I., et al.
Published: (2011)

Triterpenoids and sesquiterpenoids for prostate cancer therapy
by: Shanmugam, M., et al.
Published: (2016)

Hippo circuitry and the redox modulation of hippo components in cancer cell fate decisions
by: Ashraf, A., et al.
Published: (2015)

FLIP: A flop for execution signals
by: Subramaniam, K., et al.
Published: (2013)

Pharmacological utilization of bergamottin, derived from grapefruits, in cancer prevention and therapy
by: Ko, J., et al.
Published: (2018)

Repressing the activity of protein kinase CK2 releases the brakes on mitochondria-mediated apoptosis in cancer cells
by: Hanif, I., et al.
Published: (2011)

The TRAIL to cancer therapy: hindrances and potential solutions
by: Wong, Sonia How Ming, et al.
Published: (2019)

NF-κB in cancer therapy
by: Li, F., et al.
Published: (2015)

Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancer
by: Shanmugam, M., et al.
Published: (2012)

Redox inhibition of protein phosphatase PP2A: Potential implications in oncogenesis and its progression
by: Raman, D., et al.
Published: (2019)

The effect of hypoxia and reoxygenation on STAT3 regulation in potential cardiomyocyte models
by: Evans, Emma Louise
Published: (2012)

Unphosphorylated dimers are not required for the assembly of active STAT1 and STAT3 homo-and heterodimers
by: Krause, Sebastian C.
Published: (2023)

Comparison of the effect inhibitors have on an isostructural pair of salts
by: Jones, Franca, et al.
Published: (2005)

STAT2 is a pervasive cytokine regulator due to its inhibition of STAT1 in multiple signaling pathways
by: Ho, Johnathan, et al.
Published: (2016)

STAT2 is a pervasive cytokine regulator due to its inhibition of STAT1 in multiple signaling pathways
by: Ho, Johnathan, et al.
Published: (2016)

Molecular Targets of Ascochlorin and Its Derivatives for Cancer Therapy
by: Min-Wen, J., et al.
Published: (2017)

Future skills : Developing skills for jobs that do not yet exist in sectors that have not yet been invented
by: Alasdair White,
Published: (2022)

Recent advances in apoptosis, mitochondria and drug resistance in cancer cells
by: Indran, I., et al.
Published: (2011)

Adaptive therapy to circumvent drug resistance to tyrosine kinase inhibitors in cancer: is it clinically relevant?
by: Hamdi, Amir Imran Faisal, et al.
Published: (2022)

Redox regulation of cancer cell migration and invasion
by: Tochhawng, L., et al.
Published: (2013)